Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) - Share price - Overview


Stock Report

Lexicon Pharmaceuticals Inc LXRX

Last Price
$7.74

Day Change
-0.06|-0.77%

As of 20/03/2019
19:41:09 EDT | USD
Minimum 15 Minutes Delay.

Last Close7.80
Day Range7.66 - 8.26
Mkt Cap822.50Mil
52-Wk Range4.26 - 13.97
Yield %-
ISINUS5288723027
Volume1,236,226
P/E-6.79
P/S12.95
P/CF-5.51

Share Price

Financials
201620172018
More ...
Income Statement
Revenue83.3490.3463.21
Operating Income-137.86-134.58-103.28
Net Income-141.43-129.05-120.55
Basic EPS-1.36-1.23-1.14
Avg. Diluted Shares Outstanding104105106
Balance Sheet
Current Assets357.87322.00173.32
Non Current Assets117.75114.54110.81
Total Assets475.63436.54284.14
Current Liabilities164.64124.1336.75
Total Liabilities318.22384.44310.54
Total Equity157.4052.10-26.41
Cash Flow
Operating Cash Flow-175.63-185.39-148.61
Capital Expenditure-0.23-0.23-0.10
Free Cash Flow-175.86-185.62-148.70

In millions, except "Basic EPS". Currency is USD.

Company Profile

Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

202
Key Stats
More ...
Price/Earning TTM-6.84
Price/Book-31.39
Price/Sales TTM10.46
Rev Growth (3 year avg)-21.37
EPS Growth (3 year avg)-
Operating Margin % TTM-163.39
Net Margin % TTM-190.71
ROE TTM-938.23
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.